Skip to main content

HomeTeriparatideLegal status

Educational — Not Legal AdviceReviewed

Is Teriparatide legal? FDA status and US regulatory standing

Current status

FDA-approved. Teriparatide is an FDA-approved drug (status recorded ).

Primary source: www.accessdata.fda.gov

Federal legal status

FDA approval status

Teriparatide is an FDA-approved drug. FDA-approved parathyroid hormone 1-34 analog. Forteo (NDA 021318, Nov 2002) for osteoporosis. Biosimilar Bonsity (NDA 210842, Jan 2020) also approved. Prescription only.

Also known as

Forteo · PTH 1-34 · Parathyroid Hormone 1-34

Status history

  • Teriparatide is an FDA-approved drug. [source]

Frequently asked questions

Is Teriparatide FDA approved?
Teriparatide is an FDA-approved drug (status recorded 2002-11-26). Primary source linked on this page.
Can doctors prescribe Teriparatide?
Teriparatide is listed as prescription-availability in the PeptideBase library. Prescribing rules vary by state and prescriber licensure — consult a licensed clinician.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.